Sanjivani Paranteral Ltd.

Financial

	Sanjivani Paranteral	Ambalal Sarabhai Ent	Everest Organics
Operational Metrics
Pharmaceutical Sector
Quarterly Sales Volume - Injectables	n/a	n/a	n/a
Quarterly Sales Volume - Orals	n/a	n/a	n/a
Quarterly Sales Volume - Nutraceuticals	n/a	n/a	n/a
Financials
5 yr Average ROE	-37.68 %	24.68 %	12.73 %
5yr average Equity Multiplier	-1.69	2.5	3.91
5yr Average Asset Turnover Ratio	1.39	0.75	1.13
5yr Avg Net Profit Margin	7.02 %	12.49 %	2.92 %
Price to Book	9.34	2.15	7.51
P/E	41.57	21.22	0.0
5yr Avg Cash Conversion Cycle	-55.03 Days	-44.39 Days	-87.83 Days
Inventory Days	28.68 Days	34.61 Days	61.25 Days
Days Receivable	21.4 Days	54.38 Days	142.15 Days
Days Payable	284.6 Days	160.49 Days	226.8 Days
5yr Average Interest Coverage Ratio	15.99	10.58	3.02
5yr Avg ROCE	-87.74 %	29.87 %	19.01 %
5yr Avg Operating Profit Margin	9.71 %	4.12 %	6.68 %
5 yr average Debt to Equity	-0.72	0.39	0.84
5yr CAGR Net Profit	n/a	-16.58 %	-58.15 %
5yr Average Return on Assets	11.72 %	9.85 %	3.96 %
Shareholdings
Promoter Holding	28.87 %	31.35 %	61.09 %
Share Pledged by Promoters	0.0	0.0	0.0
Change in Promoter Holding (3 Yrs)	1.52 %	0.59 %	-13.06 %
Change in Mutual Fund Holding (3 Yrs)	0.0	0.0	0.0

Business

	Sanjivani Paranteral	Ambalal Sarabhai Ent	Everest Organics
Product Wise Break-Up	Product Wise Break-Up Injectables 50.0 Tablets 42.6 Nutraceuticals 7.4 Electronics 0 Pharmaceuticals 0 Fenofibrate 0 Oseltamivir 0 Rabeprazole 0 Dexlansoprazole 0 Tetralone 0 Ammonium Sulphate 0 Pantaprazole Sodium 0 Esomeprazole Magnesium 0 Op. Sulphide 0 Chloro Compound 0 Benzimidazole 0 Omeprazole Powder 0	Product Wise Break-Up Pantaprazole Sodium 0 Dexlansoprazole 0 Ammonium Sulphate 0 Nutraceuticals 0 Tetralone 0 Rabeprazole 0 Pharmaceutical 62.28 Oseltamivir 0 Tablets 0 Op. Sulphide 0 Electronics 37.72 Chloro Compound 0 Fenofibrate 0 Benzimidazole 0 Omeprazole Powder 0 Esomeprazole Magnesium 0 Injectables 0	Product Wise Break-Up Pantaprazole Sodium 5.59 Dexlansoprazole 0.43 Ammonium Sulphate 0 Nutraceuticals 0 Tetralone 0 Rabeprazole 5.3 Pharmaceuticals 0 Oseltamivir 0 Tablets 0 Op. Sulphide 0 Electronics 0 Chloro Compound 0 Fenofibrate 3.38 Benzimidazole 0 Omeprazole Powder 46.36 Esomeprazole Magnesium 38.94 Injectables 0
Location Wise Break-Up	Location Wise Break-Up Middle East & Africa 41.2 Latin America 29.4 India 28.0 CIS Countries 1.4 Rest of the World 0	Location Wise Break-Up Latin America 0 India 67.6 Rest of the World 32.4 Middle East & Africa 0 CIS Countries 0	Location Wise Break-Up Latin America 0 India 73.7 Rest of the World 26.3 Middle East & Africa 0 CIS Countries 0